Exploiting QSAR methods in lead optimization

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 4, 2006, Pages 419-424

  Brown, Nathan ^a   Lewis, Richard A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Extrapolation; Inverse QSAR; Overfitting; QSAR

Indexed keywords

CHEMICAL STRUCTURE; MOLECULAR MODEL; PREDICTIVE VALIDITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

MODELS, CHEMICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL;

EID: 33745994550     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Biller SA, Custer L, Dickenson KE, Durham SK, Gavai AV, Hamann LG, Josephs JL, Moulin F, Pearl GM, Flint OP, Sanders M et al. The challenge of quality in candidate optimization. In: Pharmaceutical Profiling in Drug Discovery for Lead Selection. Borchardt RT, Kerns EH, Lipinski CA, Thakker DR, Wang B (Eds), AAPS Press, Arlington, VA, USA (2004):413-429.
2. Sutherland JJ, O'Brien LA, Weaver DF: A comparison of methods for modeling quantitative structure-activity relationships. J Med Chem (2004) 47(22):5541-5554.
3. Van Drie JH: Pharmacophore discovery: A critical review. In: Computational Medicinal Chemistry for Drug Discovery. Bultinck P, Tollenaere JP, de Winter H, Langenaeker W (Eds), Marcel Dekker Inc, New York, NY, USA (2004):437-460.
4. Akarnatsu M: Current state and perspectives of 3D-QSAR. Curr Top Med Chem (2002)2(12):1381-1394.
5. Lipinski CA, Lombarde F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (1997)46(1-3):3-26.
6. Marchand-Geneste N, Watson KA, Alsberg BK, Kings RD: New approach to pharmacophore mapping and QSAR analysis using inductive logic programming. Application to thermolysln inhibitors and glycogen phosphorylase B inhibitors. J Med Chem (2002) 45(2):399-409.
7. Abraham MH, Ibrahim A, Zissimos AM, Zhao YH, Comer J, Reynolds DP: Application of hydrogen bonding calculations in property based drug design. Drug Disc Today (2002)7(20):1056-1063.
8. Clark DE: Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci(2000)88(8):807-814.
9. Hawkins DM: The problem of overfitting. J Chem Int Comput Sci (2004)44(1):1-12. Extensive overview of the issues to consider in models and overfilling with a set of heuristics, and providing best practice in modeling.
10. Schneider G, Fechner U: Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov (2005)4(8):649-663.
11. Hastie T, Tibshirani R, Friedman JH (Eds): The Elements of Statistical Learning - Data Mining, Inference and, Prediction. Springer-Verlag, New York, NY, USA (2001).
12. Slouch TR, Kenyon JR, Johnson SR, Chen XQ, Doweyko A, Li Y: In silico ADME/Tox: Why models fail. J Comput Aided Mol Des (2003) 17(2-4):83-92. Clear articulation of the importance of data quality in QSAR modeling.
13. Lombardo F, Gifford E, Shalaeva MY: In silico ADME prediction: Data models, facts and myths. Mini Rev Med Chem (2003) 3(8):861-875.
14. Eriksson L, Jaworska J, Worth AP, Cronin MT, McDowell RM, Gramatica P: Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect (2003) 111(10):1361-1375.
15. Chohan KK, Paine SW, Mistry J, Barton P, Davis AM: A rapid computational filter for cytochrome P450 1A2 inhibition potential of compound libraries. J Med Chem (2005) 48(16):5154-5161.
16. Guha R, Jurs PC: Determining the validity of a QSAR model - A classification approach. J Chem lnf Model (2005) 45(1):65-73.
17. Sheridan RP, Feuston BP, Maiorov VN, Kearsley SK: Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR. J Chem Int Comput Sci (2004) 44(6):1912-1928. First clear analysis of prediction accuracy in QSAR models.
18. Visco DP Jr, Pophale RS, Rintoul MD, Faulon JL: Developing a methodology for an inverse quantitative structure-activity relationship using the signature molecular descriptor. J Mol Graph Model (2002) 20(6):429-438.
19. Churchwell CJ, Rintoul MD, Martin S, Visco DP Jr, Kotu A, Larson RS, Sillerud LO, Brown DC, Faulon J-L: The signature molecular descriptor: 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides. J Mol Graph Model (2004) 22(4):263-273.
20. de Julián-Ortiz JV: Virtual Darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening. Comb Chem High Throughput Screen (2001) 4(3):295-310.
21. Hall LH, Fisk JB: Computer generation of vertex degree sets for chemical graphs from a number of vertices and rings. J Chem Int Comput Sci (1994) 34(5):1184-1189.
22. Sheridan RP, Hunt P, Culberson JC: Molecular transformations as a way of finding and exploiting consistent local QSAR. J Chem Int Model (2006) 46(1):180-192.
23. Lameijer E-W, Kok JN, Back T, Ijzerman AP: The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like molecules. J Chem Int Mod (2006) 46(2):545-552.
24. Brown N, McKay B, Gilardoni F, Gasteiger J: A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules. J Chem Inf Comput Sci (2004) 44(3): 1079-1087.
25. Brown N, McKay B, Gasteiger J: The de novo design of median molecules within a property range of interest J Comput Aided Mol Des (2004) 18(12):761-771. Application of the median molecule workflow to optimize structures through molecular similarity, thereby providing a controlled method for exploring chemistry space around extant molecules of interest.
26. Lewis RA: A general method for exploiting QSAR models in lead optimization. J Med Chem (2005) 48(5): 1638-1648. First description of a practical general scheme for inverse QSAR.
27. McKenna JM, Halley F, Souness JE, McLay IM, Pickett SD, Collis AJ, Page K, Ahmed I: An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J Med Chem (2002) 45(11):2173-2184.
28. Wright T, Gillet VJ, Green DVS, Pickett SD: Optimizing the size and configuration of combinatorial libraries. J Chem Inf Comput Sci (2003) 43(2):381-390.